Fixed Combination for the Treatment of Dyslipidaemia

被引：0
|
作者：
Nicola Ferri
Massimiliano Ruscica
Raul D. Santos
Alberto Corsini
机构：
[1] University of Padova,Department of Medicine (DIMED)
[2] Veneto Institute of Molecular Medicine (VIMM),Department of Pharmacological and Biomolecular Sciences “Rodolfo Paoletti”
[3] University of Milan,Lipid Clinic, Heart Institute (InCor)
[4] Department of Cardio-Thoracic-Vascular Diseases – Foundation IRCCS Cà Granda Ospedale Maggiore Policlinico,undefined
[5] University of São Paulo,undefined
[6] Hospital Israelita Albert Einstein,undefined
来源：
Current Atherosclerosis Reports | 2023年 / 25卷
关键词：
Statins; Bempedoic acid; Ezetimibe; Fenofibrate; Combinations; Polypill;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：691 / 699
页数：8
相关论文
共 50 条
  • [41] Importance of Dyslipidaemia Treatment in Individuals with Type 2 Diabetes Mellitus-A Narrative Review
    Strikic, Dominik
    Vujevic, Andro
    Perica, Drazen
    Leskovar, Dunja
    Paponja, Kristina
    Pecin, Ivan
    Mercep, Iveta
    DIABETOLOGY, 2023, 4 (04): : 538 - 552
  • [42] Niaspan® in the management of dyslipidaemia:: the evidence
    Brown, B. Greg
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2006, 8 (0F) : F60 - F67
  • [43] Dyslipidaemia in the elderly: to treat or not to treat?
    Katsiki, Niki
    Kolovou, Genovefa
    Perez-Martinez, Pablo
    Mikhailidis, Dimitri P.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (03) : 259 - 278
  • [44] Dyslipidaemia in elderly and stroke patients
    Kahali, Dhiman
    INDIAN HEART JOURNAL, 2024, 76 : S75 - S79
  • [45] Efficacy and safety of fixed-dose combination therapy with gemigliptin (50 mg) and rosuvastatin compared with monotherapy in patients with type 2 diabetes and dyslipidaemia (BALANCE): A multicentre, randomized, double-blind, controlled, phase 3 trial
    Bae, Ji Cheol
    Min, Kyung Wan
    Kim, Yong Hyun
    Kim, Kyoung-Ah
    Hong, Eun-Gyoung
    Park, Cheol-Young
    Han, Song
    Cha, Bong-Soo
    DIABETES OBESITY & METABOLISM, 2019, 21 (01) : 103 - 111
  • [46] Reduction of High Cholesterol Levels by a Preferably Fixed-Combination Strategy as the First Step in the Treatment of Hypertensive Patients with Hypercholesterolemia and High/Very High Cardiovascular Risk: A Consensus Document by the Italian Society of Hypertension
    Grassi, Guido
    Del Pinto, Rita
    Agabiti Rosei, Claudia
    Agnoletti, Davide
    Borghi, Claudio
    Cicero, Arrigo F. G.
    De Ciuceis, Carolina
    Desideri, Giovambattista
    Grassi, Davide
    Muiesan, Maria Lorenza
    Paini, Anna
    Salvetti, Massimo
    Tocci, Giuliano
    Veglio, Franco
    Volpe, Massimo
    Ferri, Claudio
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2022, 29 (02) : 105 - 113
  • [47] Projected impact of treatment intensification with statin, ezetimibe, and statin plus ezetimibe fixed-dose combination on MACE across six countries
    Farnier, Michel
    Santos, Raul D.
    Cosin-Sales, Juan
    Ezhov, Marat, V
    Liu, Jian
    Granados, Denis
    Santoni, Serena
    Khan, Irfan
    Catapano, Alberico L.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 29 (17) : 2264 - 2271
  • [48] Pharmacokinetic and pharmacodynamic evaluation of nano-fixed dose combination for hypertension
    Pandey, Avaneesh K.
    Shafiq, Nusrat
    Bhandari, Ritika K.
    Rather, Imraan I. G.
    Kaur, Navjot
    Bhatia, Alka
    Sharma, Sadhna
    Malhotra, Samir
    JOURNAL OF HYPERTENSION, 2020, 38 (08) : 1593 - 1602
  • [49] Prevalence of dyslipidaemia in statin-treated patients in South Africa: results of the DYSlipidaemia International Study (DYSIS)
    Raal, Frederick J.
    Blom, Dirk J.
    Naidoo, Shanil
    Bramlage, Peter
    Brudi, Philippe
    CARDIOVASCULAR JOURNAL OF AFRICA, 2013, 24 (08) : 330 - 338
  • [50] Implementing Fixed Dose Combination Medications for the Prevention and Control of Cardiovascular Diseases
    Webster, Ruth
    Murphy, Adrianna
    Bygrave, Helen
    Ansbro, Eimhin
    Grobbee, Diederick E.
    Perel, Pablo
    GLOBAL HEART, 2020, 15 (01)
12345